The current price of TBI is $12.36 — it has increased by 25.61% since the previous close. Data as of Nov 5, 2026.
TBI is up 27.03% over the past week, up 37.79% over the past month and up 144.75% over the past year. The price is above its 200-day moving average of $6.86.
Analysts' average 12-month price target for TBI is $9.50, which implies 23.14% downside from the current price. Individual estimates range from $9.50 to $9.50.
Of the 2 analysts covering TrueBlue, Inc., 1 rates it a buy and 1 rates it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
TrueBlue, Inc. has a market capitalization of $376.29M. The company belongs to the Industrials sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, TrueBlue, Inc. posted earnings of $0.33 per share against an estimate of $0.1867, beating expectations by 76.75%. Upcoming reports are listed in the earnings calendar.
TrueBlue, Inc. reported revenue of $520.74M in its most recent quarter, which has increased by 20.75% compared with the same quarter a year earlier. Analysts had expected $468.06M.
TrueBlue, Inc. has not paid any dividends over the past year.
Companies most comparable to TrueBlue, Inc. include Tema Electrification ETF, HireQuest, Inc., Microvast Holdings, Inc., Taylor Devices, Inc. and Forrester Research, Inc.
In the latest trading session TBI moved between $11.70 and $13.47, a range of 14.28% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of TrueBlue, Inc. shows a strong buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for TrueBlue, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks TBI has traded between $3.18 and $13.59. The current price is 9.05% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.